Practical synthesis and SAR study of aliskiren: An orally active human renin inhibitor

被引:0
|
作者
Dong, Hua [1 ]
Zhang, Zhi-Liu [1 ]
Huang, Lia-Hui [1 ]
Ma, Rujian [1 ]
Chen, Shu-Hui [1 ]
Li, Ge [1 ]
机构
[1] WuXi PharmaTech Co Ltd, Shanghai 200131, Peoples R China
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
341-MEDI
引用
收藏
页码:U2696 / U2696
页数:1
相关论文
共 50 条
  • [1] Practical synthesis of an orally active renin inhibitor aliskiren
    Dong, H
    Zhang, ZL
    Huang, JH
    Ma, RJ
    Chen, SH
    Li, G
    TETRAHEDRON LETTERS, 2005, 46 (37) : 6337 - 6340
  • [2] A new synthesis of the orally active renin inhibitor aliskiren
    Slade, Joel
    Liu, Hui
    Prashad, Mahavir
    Prasad, Kapa
    TETRAHEDRON LETTERS, 2011, 52 (33) : 4349 - 4352
  • [3] Aliskiren: An orally active renin inhibitor
    Wal, Pranay
    Wal, Ankita
    Rai, Awani K.
    Dixit, Anuj
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2011, 3 (02): : 189 - 193
  • [4] Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension
    Nussberger, J.
    Gradman, A. H.
    Schmieder, R. E.
    Lins, R. L.
    Chiang, Y.
    Prescott, M. F.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (09) : 1461 - 1468
  • [5] AN ORALLY ACTIVE INHIBITOR OF HUMAN RENIN
    KOKUBU, T
    HIWADA, K
    MURAKAMI, E
    MUNETA, S
    KITAMI, Y
    MORISAWA, Y
    KOIKE, H
    TAKAHAGI, H
    IIJIMA, Y
    NISHIMURA, K
    SALMON, PF
    HYPERTENSION, 1989, 14 (03) : 357 - 357
  • [6] Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure
    Seed, Alison
    Gardner, Roy
    McMurray, John
    Hillier, Chris
    Murdoch, David
    MacFadyen, Robert
    Bobillier, Alain
    Mann, Jessica
    McDonagh, Theresa
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (11) : 1120 - 1127
  • [7] AN ORALLY ACTIVE INHIBITOR OF RENIN
    PALS, DT
    THAISRIVONGS, S
    LAWSON, JA
    KATI, WM
    TURNER, SR
    DEGRAAF, GL
    HARRIS, DW
    JOHNSON, GA
    HYPERTENSION, 1986, 8 (12) : 1105 - 1112
  • [8] Changes in plasma renin match the antihypertensive effects of aliskiren in patients with hypertension: Placebo/irbesartan-controlled trial with the orally active renin inhibitor aliskiren
    Nussberger, J
    Gradman, AH
    Schmieder, RE
    Lins, RL
    White, WB
    Prescott, M
    Chiang, YT
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 234A - 234A
  • [9] AN ORALLY ACTIVE INHIBITOR OF HUMAN RENIN, ES-8891
    KOKUBU, T
    HIWADA, K
    MURAKAMI, E
    MUNETA, S
    KITAMI, Y
    OIZUMI, K
    TAKAHAGI, H
    KOIKE, H
    CARDIOVASCULAR DRUG REVIEWS, 1991, 9 (01): : 49 - 58
  • [10] ES-8891, AN ORALLY ACTIVE INHIBITOR OF HUMAN RENIN
    KOKUBU, T
    HIWADA, K
    MURAKAMI, E
    MUNETA, S
    KITAMI, Y
    SALMON, PF
    HYPERTENSION, 1990, 15 (06) : 909 - 913